Investor Kaufman Jonathan H
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Kaufman Jonathan H . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-04-09 13D/A LIPO / Lipella Pharmaceuticals Inc. 212,290 212,290
2025-04-07 13D/A LIPO / Lipella Pharmaceuticals Inc. 212,289 212,290
2025-03-19 13D/A LIPO / Lipella Pharmaceuticals Inc. 212,289 212,289
2025-03-17 13D/A LIPO / Lipella Pharmaceuticals Inc. 212,289 212,289
2025-03-11 13D/A LIPO / Lipella Pharmaceuticals Inc. 212,289 212,289
2025-03-03 13D/A LIPO / Lipella Pharmaceuticals Inc. 212,289 212,289
2025-02-10 13D/A LIPO / Lipella Pharmaceuticals Inc. 212,289
2025-01-30 13D/A LIPO / Lipella Pharmaceuticals Inc. 212,289
2025-01-23 13D/A LIPO / Lipella Pharmaceuticals Inc. 212,289
2025-01-17 13D/A LIPO / Lipella Pharmaceuticals Inc. 212,289
2025-01-03 13D/A LIPO / Lipella Pharmaceuticals Inc. 212,289
2024-12-27 13D/A LIPO / Lipella Pharmaceuticals Inc. 1,698,348 212,289
2024-10-17 13D/A LIPO / Lipella Pharmaceuticals Inc. 1,608,349 1,698,348
2024-05-06 13D/A LIPO / Lipella Pharmaceuticals Inc. 1,635,015 1,608,349
2024-03-19 13D/A LIPO / Lipella Pharmaceuticals Inc. 1,500,015 1,635,015
2024-03-15 13D/A LIPO / Lipella Pharmaceuticals Inc. 1,355,109 1,500,015
2024-03-06 13D/A LIPO / Lipella Pharmaceuticals Inc. 1,268,443 1,355,109
2023-06-21 13D/A LIPO / Lipella Pharmaceuticals Inc. 1,155,608 1,268,443
2022-12-29 13D LIPO / Lipella Pharmaceuticals Inc. 1,155,608